Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending October 2011. The report details a specific corporate action regarding the repurchase of the company's own ordinary shares, executed in accordance with shareholder authority granted at the Annual General Meeting on May 5, 2011.
Key Financial Metrics
The filing does not provide comprehensive financial statements such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to the share repurchase transaction on October 14, 2011:
- Shares Purchased: 250,000 ordinary shares of 25 pence each.
- Price Range: Highest price paid was 1,385.5 pence per share; lowest price paid was 1,365 pence per share.
- Treasury Holdings: Post-transaction, the company holds 506,626,370 shares in Treasury (9.10% of total issued share capital).
- Total Voting Rights: Including unsettled purchases, Treasury holdings represent 10.02% of current total voting rights.
- Shares in Issue: 5,063,546,717 shares (excluding Treasury shares).
Material Changes
The material change reported is the reduction of outstanding shares through the repurchase of 250,000 shares. Consequently, the percentage of shares held in Treasury increased to 9.10% of total issued share capital. The filing does not provide comparative data against prior periods for operational metrics.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or discussion of risks and contingencies beyond the standard disclosure that the announcement does not constitute an offer to purchase securities. The company intends to hold the repurchased shares in Treasury.
Investor Verification Checklist
- Verify the total number of shares in issue (5,063,546,717) for calculating disclosure thresholds under Financial Services Authority rules.
- Confirm the updated Treasury share count (506,626,370) and its impact on total voting rights (10.02% including unsettled trades).
- Note that this filing is a transactional report and does not contain quarterly or annual financial performance data.